This discussion will be led by program staff and leadership from NCI and NINDS on institute research priorities as well as various opportunities for early career investigators within their IC.
This session will be led by Lalitha K. Shankar, MD, PhD, FSNMMI, Chief of the Clinical Trials Branch and Acting Associate Director of the Cancer Imaging Program, and Debra Babcock, MD, PhD, Program Director at NINDS.
This session is mandatory for the 2024-25 CECI² Class.




